COLL — Collegium Pharmaceutical Share News
0.000.00%
Last trade - 00:00- $765.06m
- $1.85bn
- $780.57m
U.S. RESEARCH ROUNDUP-Blackstone, First Solar, Valero Energy
Brief: Collegium Provides 2024 Financial Guidance
Brief: Collegium Pharmaceutical Outlook FY Adjusted EBITDA USD 380-395 Million
Brief: Collegium Pharmaceutical U.S. Court Of Appeals For Federal Circuit Upheld Judgment Of PTAB In Final Decision
Brief: Collegium Announces $25 Mln Accelerated Share Repurchase Program
Brief: Collegium Pharmaceutical Q3 Revenue USD 136.7 Million Vs. IBES Estimate USD 138.3 Million
Collegium Pharmaceutical Inc expected to post earnings of 52 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Autodesk, Intuit, Workday
Brief: Collegium Announces $50 Million Accelerated Share Repurchase Program
U.S. RESEARCH ROUNDUP-Airbnb, Cummins, Meta Platforms
Collegium Pharmaceutical Inc reports results for the quarter ended in June - Earnings Summary
Brief: Collegium Pharmaceutical Q2 Revenue USD 135.5 Million Vs. IBES Estimate USD 138.4 Million
Collegium Pharmaceutical Inc expected to post earnings of 29 cents a share - Earnings Preview
Collegium Pharmaceutical Inc expected to post earnings of 31 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Booking Holdings, Coca-Cola, Zebra Technologies
FDA mandates new safety warnings for opioid pain medicines
U.S. RESEARCH ROUNDUP-C4 Therapeutics, Nvidia, WW Grainger
Brief: Collegium Reports Fourth Quarter And Full-Year 2022 Financial Results
Brief: Collegium Pharmaceutical Reports Fourth Quarter and Full-Year 2022 Financial Results